Literature DB >> 1234016

The distribution of quinidine in human blood.

I E Hughes, K F Ilett, L B Jellett.   

Abstract

The uptake of quinidine by washed human red blood cells from isotonic buffer solution (pH 7.4) occurred rapidly and was proportional to the concentration of drug in buffer. A constant red cell/buffer partition ratio of 4.16+/-0.15 s.e. mean was found. 2. Uptake from buffer solution was not affected by temperature or ouabain or by gassing with nitrogen or carbon monoxide and there was no evidence of saturability. Drug in red blood cells was associated largely with the cell contents (94.4+/-1.5% s.e. mean) following partition. 3 Plasma reduced the uptake of quinidine so that a red cell/plasma partition ratio of 0.82+/-0.09 s.e. mean was found. 4 Alteration of plasma binding by dilution of plasma with buffer showed that uptake was proportional to free drug concentration. 5 The possibility of red cell uptake of drug should be included in any considerations concerning pharmacokinetic aspects of drug action in the body.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234016      PMCID: PMC1402636          DOI: 10.1111/j.1365-2125.1975.tb00570.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

Authors:  J T DODGE; C MITCHELL; D J HANAHAN
Journal:  Arch Biochem Biophys       Date:  1963-01       Impact factor: 4.013

2.  Passage of organic bases into human red cells.

Authors:  L S SCHANKER; P A NAFPLIOTIS; J M JOHNSON
Journal:  J Pharmacol Exp Ther       Date:  1961-09       Impact factor: 4.030

3.  The relation between the binding of sulfonamides to albumin and their antibacterial efficacy.

Authors:  A H ANTON
Journal:  J Pharmacol Exp Ther       Date:  1960-07       Impact factor: 4.030

4.  The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.

Authors:  G H Evans; A S Nies; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

5.  Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells.

Authors:  P Borondy; W A Dill; T Chang; R A Buchanan; A J Glazko
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

6.  Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

7.  Quinidine elimination in patients with congestive heart failure or poor renal function.

Authors:  K M Kessler; D T Lowenthal; H Warner; T Gibson; W Briggs; M M Reidenberg
Journal:  N Engl J Med       Date:  1974-03-28       Impact factor: 91.245

8.  Erythrocyte uptake and plasma binding of diphenylhydantoin.

Authors:  D Kurata; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1974-08       Impact factor: 6.875

9.  Drug therapy. Serum drug concentrations as therapeutic guides.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

10.  Comparison of two methods for quinidine determination and chromatographic analysis of the difference.

Authors:  G Härtel; A Harjanne
Journal:  Clin Chim Acta       Date:  1969-02       Impact factor: 3.786

View more
  12 in total

1.  Plasma level of chlormethiazole and two metabolites after oral administration to young and aged human subjects.

Authors:  R L Nation; J Vine; E J Triggs; B Learoyd
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

Review 2.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

3.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; H Harashima; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

4.  Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.

Authors:  H Harashima; Y Sawada; Y Sugiyama; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

5.  The influence of various factors in the in vitro distribution of haloperidol in human blood.

Authors:  I E Hughes; L B Jellett; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

6.  Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method.

Authors:  M E Veronese; S McLean; R Hendriks
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of quinidine.

Authors:  H R Ochs; D J Greenblatt; E Woo
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

8.  Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease.

Authors:  R J Shirkey; L B Jellett; D C Kappatos; T J Maling; A Macdonald
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 9.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

10.  Quinine and quinidine inhibit and reveal heterogeneity of K-Cl cotransport in low K sheep erythrocytes.

Authors:  N C Adragna; P K Lauf
Journal:  J Membr Biol       Date:  1994-11       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.